Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.
about
The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with InflammationAntitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein.Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.Effect of vitamin E succinate on the expression of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor in gastric cancer cells and CD4(+) T cells.TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy.Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways.pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.Bone marrow stem cells modified with human interleukin 10 attenuate acute rejection in rat lung allotransplantation.Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells.Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.
P2860
Q28073691-20C01987-7A90-47A0-B966-EEFDFACB18DAQ33658976-2BEBF6B1-FADF-4D3E-9B68-DD270A29ACB3Q37000249-BC178A63-80C3-40A7-8CC6-A82C8FF3DC38Q38715325-7FC122B2-8020-41A5-954F-271C2572D5A9Q38750240-972181BF-756F-4D1E-B6C6-E5FD96CA842BQ38834785-4E4D6831-1E57-4D91-BB24-180A878B0062Q38888391-D2479503-C037-406F-B72C-326FFBE3BEBEQ39368381-6B840203-F7FD-4D5F-A92F-60C3AAF0D219Q42368100-FDC687A3-826D-4437-A611-4CF29D0EE3DFQ45872492-1BD55889-D929-4D26-A3E9-604295B797FEQ47148289-0DC532CA-2DF6-4FCE-8B71-FC0F3E4425A5Q47653923-4AC91209-ACCE-4C38-9107-1BAF2DA018F2Q52608756-EAD352EC-35F7-40FA-8617-3B42F29C5FA6
P2860
Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Mesenchymal stromal cell deliv ...... luble type for cancer therapy.
@en
type
label
Mesenchymal stromal cell deliv ...... luble type for cancer therapy.
@en
prefLabel
Mesenchymal stromal cell deliv ...... luble type for cancer therapy.
@en
P2093
P2860
P1433
P1476
Mesenchymal stromal cell deliv ...... oluble type for cancer therapy
@en
P2093
Elizabeth K Sage
Kate H C Gowers
Krishna K Kolluri
ZhengQiang Yuan
P2860
P304
P356
10.1016/J.JCYT.2015.03.603
P50
P577
2015-04-14T00:00:00Z